Replies to post #27090 on Ayala Pharmaceuticals Inc (ADXS)

[DewDiligence]

Contrary to some opinions expressed on this board, I like the way the BOD are being tight-lipped regarding the path forward for the company after the DOC resignation. IMHO, Vague is Good.

Most investors value transparency (within reason).

The sell-off immediately following Investor Day in June was not caused by transparency per se, but rather by the revelation that AZN was no longer interested in AXAL and the inferences investors drew from knowing that.